Swedish Orphan Valuation
Swedish Orphan seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Swedish Orphan Biovitrum from inspecting the company fundamentals such as Operating Margin of 0.24 %, shares outstanding of 295.99 M, and Return On Equity of 0.11 as well as reviewing its technical indicators and probability of bankruptcy.
Swedish Orphan Total Value Analysis
Swedish Orphan Biovitrum is at this time anticipated to have takeover price of 72.79 B with market capitalization of 73.08 B, debt of 9.02 B, and cash on hands of 1.04 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Swedish Orphan fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
72.79 B | 73.08 B | 9.02 B | 1.04 B |
Swedish Orphan Investor Information
About 71.0% of the company shares are owned by institutional investors. The book value of Swedish Orphan was at this time reported as 89.61. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Swedish Orphan Biovitrum recorded earning per share (EPS) of 10.1. The entity had not issued any dividends in recent years. The firm had 1265:1132 split on the 3rd of May 2011. Based on the analysis of Swedish Orphan's profitability, liquidity, and operating efficiency, Swedish Orphan Biovitrum is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Swedish Orphan Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Swedish Orphan has an asset utilization ratio of 31.91 percent. This implies that the Company is making kr0.32 for each dollar of assets. An increasing asset utilization means that Swedish Orphan Biovitrum is more efficient with each dollar of assets it utilizes for everyday operations.Swedish Orphan Ownership Allocation
Swedish Orphan Biovitrum shows a total of 295.99 Million outstanding shares. The majority of Swedish Orphan Biovitrum outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Swedish Orphan to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Swedish Orphan Biovitrum. Please pay attention to any change in the institutional holdings of Swedish Orphan Biovitrum as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Swedish Orphan Profitability Analysis
The company reported the revenue of 15.53 B. Net Income was 2.68 B with profit before overhead, payroll, taxes, and interest of 14.38 B.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Tools for Swedish Stock
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |